Drug Detail:Lemborexant (Lemborexant [ lem-boe-rex-ant ])
Drug Class: Miscellaneous anxiolytics, sedatives and hypnotics
Lemborexant Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the use of lemborexant during breastfeeding. Because it is about 94% bound to plasma proteins, amounts in milk are likely to be small. If lemborexant is required by the mother, it is not a reason to discontinue breastfeeding. However, until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. Monitor the infant for sedation, poor feeding and poor weight gain.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Zaleplon, Zolpidem
Substance Identification
Substance Name
Lemborexant
CAS Registry Number
1369764-02-2
Drug Class
Breast Feeding
Lactation
Milk, Human
Hypnotics and Sedatives
Orexin Receptor Antagonists
Sleep Aids, Pharmaceutical
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification